Scientists Grow Human Sperm Precursor Cells from Stem Cells in Lab
Researchers generated spermatogonia from human iPSCs using a lab-engineered testis model, opening new doors for treating male infertility.
Summary
Male infertility often stems from failures in sperm development, but studying human spermatogenesis in the lab has been nearly impossible — until now. Researchers at the University of Pennsylvania developed a system using human induced pluripotent stem cells (iPSCs) to generate primordial germ cell-like cells, which were then organized with mouse fetal testicular cells into seminiferous tubule-like structures called xenogeneic reconstituted testes. When transplanted into immunodeficient mice, these structures produced early male germ cells, including spermatogonia and rare early spermatocytes that closely resembled their natural counterparts. The team also replicated the approach in rhesus monkey iPSCs, paving the way for primate testing before potential human therapies. This platform represents a significant step toward in vitro gametogenesis and new treatments for male infertility.
Detailed Summary
Male infertility affects roughly one in six couples worldwide, yet the biological mechanisms underlying human spermatogenesis remain poorly understood due to the absence of reliable model systems. This bottleneck has stalled therapeutic development for men whose infertility is rooted in germ cell failure.
Researchers at the University of Pennsylvania developed a two-stage platform to bridge this gap. First, they differentiated human iPSCs into primordial germ cell-like cells, then combined them with mouse fetal testicular somatic cells to create self-organizing seminiferous tubule-like structures within what they term a xenogeneic reconstituted testis, or xrTestis. These lab-built structures were subsequently transplanted into immunodeficient mice to provide a supportive in vivo environment for continued maturation.
The transplanted xrTestes efficiently generated male germ cells through meiotic onset. Key cell types produced included spermatogonia showing evidence of prepachytene PIWI-interacting RNA (piRNA) biogenesis — a marker of genuine germ cell programming — differentiating spermatogonia, and rare preleptotene spermatocytes. Transcriptomic and phenotypic analyses confirmed these cells closely resembled their natural in vivo counterparts, validating the biological fidelity of the system.
Recognizing that future clinical applications will require non-human primate validation before human trials, the team applied a comparable strategy to rhesus macaque iPSCs, successfully differentiating them through fetal germ cell stages into spermatogonia. This primate platform is a critical translational bridge between mouse models and eventual human therapies.
While this work does not yet achieve full in vitro spermatogenesis — mature sperm were not produced — it establishes a reproducible foundation for studying primate germ cell biology and developing therapies for male infertility. Caveats include reliance on mouse somatic support cells and an in vivo engraftment step, both of which introduce complexity for future clinical translation. The summary is based on the abstract only.
Key Findings
- Human iPSCs were converted into primordial germ cell-like cells that self-organized into testis-like tubule structures in the lab.
- Transplanting these lab-built testis structures into mice produced spermatogonia and early spermatocytes resembling real in vivo cells.
- Spermatogonia displayed active piRNA biogenesis, confirming authentic male germ cell identity and programming.
- The same differentiation strategy successfully produced spermatogonia from rhesus macaque iPSCs, a key translational step.
- This platform provides a new tool for studying male infertility mechanisms and developing future germ cell therapies.
Methodology
Human and rhesus macaque iPSCs were differentiated into primordial germ cell-like cells, then combined with mouse fetal testicular somatic cells to form xenogeneic reconstituted testes (xrTestes). These structures were transplanted into immunodeficient mice to support further germ cell maturation. Transcriptomic profiling and phenotypic analysis were used to validate the identity of generated cell types against in vivo counterparts.
Study Limitations
Full spermatogenesis producing mature sperm was not achieved; the platform currently reaches only early meiotic stages. The system relies on mouse somatic support cells and an in vivo engraftment step, which complicate direct clinical translation. The summary is based on the abstract only, so methodological details and full data cannot be fully assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: